GleamWall
中文EN

ENTA ENANTA PHARMACEUTICALS INC

Pharmaceutical Preparations · Nasdaq · SEC CIK 1177648 · Fiscal year ends 09/30

Financial factors as of 2026-09-30 (2026Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.6%
TTM net income YoY16.7%
TTM EPS YoY38.8%
Revenue 3-yr CAGR-7.3%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-99.0%
Net margin-108.3%
FCF margin-67.9%
EBITDA margin-91.4%

Returns

ROE-94.2%
ROA-24.5%
ROIC (approx.)-106.7%
Asset turnover0.23x

Leverage & solvency

Liabilities / assets70.9%
Debt / equity0.00x
Current ratio3.78x
Interest coverage-4.43x

Cash quality & payout

Operating cash flow / net income0.62x
Accruals ratio-9.2%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-09-30FY20252025-09-30
Income statement
Revenue$63.00M$65.32M
R&D expense$88.55M$106.74M
SG&A expense$36.84M$43.93M
Operating income-$62.38M-$85.35M
Interest expense$14.07M$7.68M
Pretax income-$68.21M-$83.55M
Income tax$40,000-$1.66M
Net income-$68.25M-$81.89M
EBITDA-$57.60M-$80.76M
EPS (basic)-2.35-3.84
EPS (diluted)-2.35-3.84
Weighted avg. shares (diluted)29.00M21.34M
Balance sheet
Cash & equivalents$20.27M$32.30M
Short-term investments$174.24M$156.57M
Receivables$5.86M$6.88M
Current assets$205.99M$204.34M
PP&E, net$30.86M$35.40M
Total assets$275.58M$280.73M
Current liabilities$54.46M$48.55M
Total liabilities$195.38M$216.01M
Shareholders' equity$80.19M$64.72M
Shares outstanding29.14M21.39M
Cash flow statement
Operating cash flow-$42.56M-$19.27M
Capital expenditure$206,000$12.90M
Free cash flow-$42.77M-$32.17M
Investing cash flow-$17.18M$40.35M
Financing cash flow$47.72M-$26.62M
Depreciation & amortization$4.78M$4.59M
Stock-based compensation$14.03M$18.57M

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.